---
title: "European stocks \"Eleven Arhats\" | Novartis, Roche, Novo Nordisk, Astrazeneca, GSK fell by a maximum of 5.6%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231415710.md"
description: "On Tuesday (March 11), the stock prices of several European pharmaceutical and consumer goods companies fell. Novartis dropped 5.6%, Roche fell 3.55%, and Astrazeneca decreased by 3.06%. Novo Nordisk's stock price fell 3.44%, nearing its historical low. Other companies such as GSK, L'Oréal, and Nestlé also experienced declines ranging from 2.73% to 2.1%. Overall, the stock price of AstraZeneca Holdings fell by 1.10%"
datetime: "2025-03-11T17:32:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231415710.md)
  - [en](https://longbridge.com/en/news/231415710.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231415710.md)
generator: "portal-rs"
---

# European stocks "Eleven Arhats" | Novartis, Roche, Novo Nordisk, Astrazeneca, GSK fell by a maximum of 5.6%

On Tuesday (March 11), ASML Holding's stock price in Amsterdam (ASML.NA) closed down 1.10% at €632.00. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) closed down 3.44% at 530.50 Danish Krone, approaching the closing prices of 517.00 on July 12, 2023, and 494.45 on March 20 of the same year, following a continuous pullback since reaching a record closing high of 1028.00 on June 25, 2024. Novartis closed down 5.6%, Roche fell 3.55%, Astrazeneca dropped 3.06%, GSK, L'Oréal, and Nestlé declined by 2.73%-2.1%, while Sanofi, LVMH Group, and SAP also fell by up to 1.86%

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [LRLCY.US](https://longbridge.com/en/quote/LRLCY.US.md)
- [NSRGY.US](https://longbridge.com/en/quote/NSRGY.US.md)
- [NSRGF.US](https://longbridge.com/en/quote/NSRGF.US.md)
- [SAP.US](https://longbridge.com/en/quote/SAP.US.md)
- [ASML.US](https://longbridge.com/en/quote/ASML.US.md)

## Related News & Research

- [Roche announces MediLink’s phase III trial of Tam-Peli met primary endpoint](https://longbridge.com/en/news/298840024.md)
- [AstraZeneca publishes transcript of ERS 2026 investor call and webcast](https://longbridge.com/en/news/298346504.md)
- [Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials](https://longbridge.com/en/news/298355260.md)
- [FOCUS-Novartis investors turn spotlight on M&A after trial setbacks](https://longbridge.com/en/news/298681304.md)
- [GSK Targets £1.9B Savings to Fuel Pipeline, Navigate HIV Patent Cliff](https://longbridge.com/en/news/298823538.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**